Related Experiment Video
Updated: Jun 5, 2026

Real-time Imaging of Axonal Transport of Quantum Dot-labeled BDNF in Primary Neurons
Published on: September 15, 2014
Brain-derived neurotrophic factor: findings in schizophrenia
Peter F Buckley1, Anilkumar Pillai, Kristy R Howell
1Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta, Georgia, USA. pbuckley@mcg.edu
Altered levels of brain-derived neurotrophic factor (BDNF) are observed in schizophrenia patients, impacting neuroplasticity. Further research is needed to confirm BDNF
Area of Science:
- Neuroscience
- Psychiatry
- Genetics
Background:
- Schizophrenia is a complex psychiatric disorder characterized by disruptions in neuroplasticity.
- Brain-derived neurotrophic factor (BDNF) plays a crucial role in neuronal survival, growth, and synaptic plasticity.
Purpose of the Study:
- To review the role of BDNF in neuroplasticity associated with schizophrenia.
- To examine recent findings on BDNF levels in schizophrenia patients and their clinical correlations.
Main Methods:
- Literature review of studies investigating BDNF in schizophrenia.
- Analysis of peripheral BDNF levels in first-episode and chronic schizophrenia patients.
- Examination of the impact of antipsychotic treatment on BDNF levels.
- Investigation of the role of BDNF Val66Met polymorphism.
Main Results:
- Peripheral BDNF levels are altered in both first-episode psychosis and chronic schizophrenia.
- Some studies indicate changes in peripheral BDNF levels after antipsychotic treatment.
- The Val66Met polymorphism of BDNF is implicated in structural and functional plasticity in schizophrenia.
Conclusions:
- Peripheral BDNF levels show potential for novel therapeutic strategies in schizophrenia.
- Further research is warranted to validate BDNF as a reliable biomarker for schizophrenia.
- Understanding BDNF's role is critical for developing targeted treatments.
More Related Videos
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
13:46An Improved Protocol to Purify and Directly Mono-Biotinylate Recombinant BDNF in a Tube for Cellular Trafficking Studies in Neurons
Published on: July 11, 2020
Related Concept Videos
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Neurogenesis and Regeneration of Nervous Tissue